Medication info

Revo Gold Liquid

OTC medicationSyrupOral
Ingredient · strength
L-Ornithine Hydrochloride›60mgL-Citrulline›60mgL-Arginine Hydrochloride›120mg
Manufacturer / importer
Korea Pharmaceutical Co., Ltd.
Appearance
A composite preparation consisting of a white powder in the upper container and a colorless to slightly yellow transparent syrup in a brown bottle.
Packaging
{([Powder part] Upper cap 230mg, [Liquid part] 15mL)/bottle}×30 {([Powder part] Upper cap 230mg, [Liquid part] 15mL)/bottle}×60 {([Powder part] Upper cap 230mg, [Liquid part] 15mL)/bottle}×1
Approval status
Active

MFDS item code 200301508 · Notified 2003.10.09

Summary

Main use
Adjunctive treatment of liver diseases (e.g., acute and chronic liver disease and mild hepatic insufficiency)
Who takes it
Adults
Adult dose
Take 1 bottle each time, 2-3 times daily.

Ingredients

Manufacturer
Korea Pharmaceutical Co., Ltd.

Efficacy & effects

Adjunctive treatment of liver diseases (e.g., acute and chronic liver disease and mild hepatic insufficiency)

  • Acute and chronic liver diseases
  • mild hepatic failure
  • loss of liver function
  • cirrhosis.
View approved original text

This medication is used as an adjunctive treatment for acute and chronic liver diseases, mild liver function impairment symptoms, and liver diseases such as cirrhosis.

How to take

Adult dose

Take 1 bottle each time, 2-3 times daily.

Precautions

This medication should not be taken by individuals who are allergic to specific ingredients. Additionally, it should not be used by those with severely impaired kidney function. Individuals whose liver function is seriously compromised to the point of coma should also refrain from taking this medication. People with metabolic issues related to amino acids, especially those with congenital enzyme deficiencies, should avoid this medication. Those who have experienced a heart attack or have a history of myocardial infarction should not take this medication. It is crucial to adhere strictly to the prescribed dosage and method of administration. If unusual symptoms occur during use, stop taking the medication immediately and consult a doctor or pharmacist. This medication should be stored in a safe place out of reach of children. Also, transferring the medication from its original container to another container can result in misuse or degradation of the quality, so it should always be kept in its original container with the cap tightly closed.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. Additionally, it should be stored at room temperature between 1°C and 30°C, away from extreme heat or cold.

Appearance and packaging

Appearance

A composite preparation consisting of a white powder in the upper container and a colorless to slightly yellow transparent syrup in a brown bottle.

Package unit

{([Powder part] Upper cap 230mg, [Liquid part] 15mL)/bottle}×30 {([Powder part] Upper cap 230mg, [Liquid part] 15mL)/bottle}×60 {([Powder part] Upper cap 230mg, [Liquid part] 15mL)/bottle}×1

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.